OXYCYTE

Details for Australian Trade Mark No. 1310933 (hide)

Owner Oxygen Biotherapeutics, Inc.

Convention US 8 December 2008 77628296

Various Convention priority claimed: 8 December 2008, United States of America, No. 77628296 in respect of CHEMICAL COMPOUNDS USED TO MANUFACTURE PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF TISSUE ISCHEMIA, BURNS, WOUNDS, TRAUMATIC BRAIN INJURY, LUNG DISORDE

Filing Date 26 May 2009

Classes

Class 1 Chemical compounds used to manufacture pharmaceutical preparations for the treatment of tissue ischemia, burns, wounds, traumatic brain injury, lung disorders, sickle cell disease, skin conditions, namely, acne, and hair conditions, namely, dandruff; chemical compounds used to manufacture pharmaceutical preparations for use in dermatology and cosmetology; chemical compounds used for oxygen transport in industrial processes

Class 5 Pharmaceutical preparations for the treatment of tissue ischemia, burns, wounds, traumatic brain injury, lung disorders, sickle cell disease, skin conditions, namely, acne, and hair conditions, namely, dandruff; pharmaceutical preparations for use in dermatology and cosmetology

Event Publications

13 August 2009 Application filed

20 August 2009 Application Accepted

17 December 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1310934

1310932-JIL SANDER